SINGAPORE & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) will present data from two global Phase 3 double-blind, placebo-controlled studies of oveporexton (TAK-861) 1, ...
Scientists successfully recreate fine chocolate taste in lab using 9 specific bacterial species isolated from Colombian cocoa farms. New pyramid symbol appears on chain restaurant menus—Here’s what it ...
Department of Chemical, Environmental and Materials Engineering, University of Miami, Miami, Florida 33124, United States ...
After beating Novo Nordisk’s semaglutide last month, Lilly’s much anticipated oral candidate orforglipron has taken down AstraZeneca’s Farxiga in a head-to-head trial. Eli Lilly’s oral GLP-1 ...
Eli Lilly released the results of two new Phase 3 trials of an experimental GLP-1 pill that the company says could become a “foundational treatment” for type 2 diabetes. The medicine, orforglipron, ...
Voters will decide the future of Colorado’s universal free school meals program this November through a pair of ballot measures sent to them by the legislature. Propositions LL and MM are aimed at ...
– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New ...
Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- ...
PORTSMOUTH, N.H.--(BUSINESS WIRE)--Iron Mountain, a global leader in information management services, and McLaren Racing today announced the company as an Official Partner of the McLaren Formula 1 ...
Preliminary data presented at the AACR-NCI-EORTC conference will provide insights into the potential of ZW191 in patients with advanced solid tumors, including ovarian cancer, endometrial cancer, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results